HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Education, workplace culture key to addressing oncology nursing shortage Jennifer Byrne
-
- Adjuvant pembrolizumab well tolerated in high-risk renal cell carcinoma Mark Leiser
- Analysis: Price of hemophilia A therapy would have to drop nearly 60% to be cost-effective Mark Leiser
- ASCO recommends future cancer clinical trials take steps to assess ovarian toxicity Matthew Shinkle
- Axatilimab represents ‘highly effective’ therapeutic strategy for chronic GVHD Drew Amorosi
- Combination may be ‘new standard’ in EGFR-mutant non-small cell lung cancer Mark Leiser
- Datopotamab deruxtecan extends PFS vs. chemotherapy in advanced breast cancer Mark Leiser
- Diabetes severity affects survival after colorectal cancer surgery Jennifer R. Southall
- Digital health coaching program for breast cancer did not improve patient-reported outcomes Jennifer R. Southall
-
- Few patients with kidney cancer who meet evaluation criteria receive genetic counseling Mark Leiser
- Findings ‘of paramount importance’ should guide oncofertility counseling for BRCA carriers Mark Leiser
- Former ASH president honored for dedication to improving care of underserved populations Josh Friedman
- Industry-funded meta-analyses more likely to have favorable conclusions Jennifer Byrne; Alyson Haslam, PhD
- Insurance delays play significant role in ongoing ‘battle’ to receive CAR T-cell therapy Drew Amorosi
- Life expectancy for people with sickle cell disease increases by a decade Mark Leiser
- Lovo-cel gene therapy ‘transformative’ for sickle cell disease Mark Leiser
- Lung cancer incidence steadily increasing among young, middle-aged U.S. women Jennifer R. Southall
-
- MD Anderson professor and ‘mentor’s mentor’ receives humanitarian award Mark Leiser
- Multiple myeloma regimens significantly less effective in real-world treatment settings Drew Amorosi
- New approaches show promise for treatment of gastroesophageal cancers Jennifer R. Southall
- New guidance recommends yearly lung cancer screening for millions more US adults Jennifer Byrne
- Pembrolizumab increases response in resectable gastric, gastroesophageal junction cancers Mark Leiser
- Redispensing unused oral cancer drugs reduces costs, waste Matthew Shinkle
- Safety profiles with immunotherapy similar among older, younger patients with breast cancer Jennifer R. Southall
- Surgery underutilized for early-stage pancreatic cancer Matthew Shinkle
-
- Tinengotinib exhibits activity in pretreated breast cancer Mark Leiser
- Trial eligibility linked to better outcomes after immunotherapy for renal cell carcinoma Mark Leiser
- Using pharmacogenomics to guide induction may reduce racial disparities in pediatric AML Josh Friedman
- Weighted blankets enhance patient experience by reducing anxiety during chemotherapy Jennifer Byrne; Megan Corbett, MSN, RN, NPD-BC, OCN
- Oncologist to lead breast cancer program at UCLA Health
- Oncology Nursing Society appoints next president
- Radiation oncologist to lead NYU Langone Health’s Perlmutter Cancer Center
- Thoracic oncologist appointed cancer center executive director
-